18 results for author:"Turkson J." in Literature citations
Results Customize
› Repeat search in UniProtKB (1)
| Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. Yue P., Zhang X., Paladino D., Sengupta B., Ahmad S., Holloway R.W., Ingersoll S.B., Turkson J. Oncogene 31:2309-2322(2012) · Mapped (19) |
| A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells. Jaganathan S., Yue P., Paladino D.C., Bogdanovic J., Huo Q., Turkson J. PLoS ONE 6:e19605-e19605(2011) · Mapped (10) |
| Stat3 controls lysosomal-mediated cell death in vivo. Kreuzaler P.A., Staniszewska A.D., Li W., Omidvar N., Kedjouar B., Turkson J., Poli V., Flavell R.A., Clarkson R.W., Watson C.J. Nat. Cell Biol. 13:303-309(2011) · Mapped (7) |
| THAP5 is a DNA-binding transcriptional repressor that is regulated in melanoma cells during DNA damage-induced cell death. Balakrishnan M.P., Cilenti L., Ambivero C., Goto Y., Takata M., Turkson J., Li X.S., Zervos A.S. Biochem. Biophys. Res. Commun. 404:195-200(2011) · Mapped (1) |
| Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten. Barbieri I., Pensa S., Pannellini T., Quaglino E., Maritano D., Demaria M., Voster A., Turkson J., Cavallo F., Watson C.J. et al. Cancer Res. 70:2558-2567(2010) · Mapped (7) |
| The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Hillion J., Dhara S., Sumter T.F., Mukherjee M., Di Cello F., Belton A., Turkson J., Jaganathan S., Cheng L., Ye Z. et al. Cancer Res. 68:10121-10127(2008) · Mapped (7) |
| Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Siddiquee K., Zhang S., Guida W.C., Blaskovich M.A., Greedy B., Lawrence H.R., Yip M.L., Jove R., McLaughlin M.M., Lawrence N.J. et al. Proc. Natl. Acad. Sci. U.S.A. 104:7391-7396(2007) · Mapped (14) |
| Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells. Anagnostopoulou A., Vultur A., Arulanandam R., Cao J., Turkson J., Jove R., Kim J.S., Glenn M., Hamilton A.D., Raptis L. Cancer Lett. 242:120-132(2006) · Mapped (20) |
| Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Xu Q., Briggs J., Park S., Niu G., Kortylewski M., Zhang S., Gritsko T., Turkson J., Kay H., Semenza G.L. et al. Oncogene 24:5552-5560(2005) · Mapped (16) |
| Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen. Vultur A., Arulanandam R., Turkson J., Niu G., Jove R., Raptis L. Mol. Biol. Cell 16:3832-3846(2005) · Mapped (22) |
| Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. Waris G., Turkson J., Hassanein T., Siddiqui A. J. Virol. 79:1569-1580(2005) · Mapped (7) |
| Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Vultur A., Cao J., Arulanandam R., Turkson J., Jove R., Greer P., Craig A., Elliott B., Raptis L. Oncogene 23:2600-2616(2004) · Mapped (7) |
| Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L., Turkson J., Karras J.G., Jove R., Haura E.B. Oncogene 22:4150-4165(2003) · Mapped (7) |
| STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues. Velichko S., Wagner T.C., Turkson J., Jove R., Croze E. J. Biol. Chem. 277:35635-35641(2002) · UniProtKB (1) · Mapped (8) |
| Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. Bild A.H., Turkson J., Jove R. EMBO J. 21:3255-3263(2002) · Mapped (8) |
| Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., Zhang S., Wang T., Sinibaldi D., Coppola D. et al. Oncogene 21:2000-2008(2002) · Mapped (14) |
| Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. Turkson J., Ryan D., Kim J.S., Zhang Y., Chen Z., Haura E., Laudano A., Sebti S., Hamilton A.D., Jove R. J. Biol. Chem. 276:45443-45455(2001) · Mapped (7) |
| STATs in oncogenesis. Bowman T., Garcia R., Turkson J., Jove R. Oncogene 19:2474-2488(2000) · Mapped (8) |